Intact and hypophysectomized freshwater (FW) silver eels were transferred to tanks of FW or artificial sea water (SW; salinity = 0·60 osmol/l) which were simultaneously renewed twice a week. Fish were killed 2 months after transfer and plasma was assayed for ovarian steroids.
In all fish, 5α-androstane-3β,17β-diol was present, while 5α-dihydrotestosterone and 5α-androstane-3α,17β-diol were undetectable.
In intact FW eels, plasma levels of testosterone, 5α-androstane-3β,17β-diol and oestradiol-17β were approximately 0·15 nmol/l. In intact SW eels, no change in plasma levels of testosterone and 5α-androstane-3β,17β-diol was found, whereas the concentration of oestradiol-17β was increased significantly (P<0·01), indicating stimulation of aromatase activity.
In hypophysectomized compared with intact FW fish, plasma levels of testosterone and 5α-androstane-3β,17β-diol were decreased (P<0·05) and there was a slight but significant (P<0·01) augmentation of the plasma concentration of oestradiol-17β which may have involved the removal of pituitary-dependent inhibition of aromatase activity, possibly by 5α-reduced compounds.
In hypophysectomized compared with intact SW fish, plasma levels of testosterone, 5α-androstane-3β,17β-diol and oestradiol-17β were decreased (P<0·05); in the case of oestradiol-17β, this may have reflected the diminished ovarian synthesis of testosterone, its precursor. The plasma level of oestradiol-17β was, however, higher in SW than in FW fish, even in hypophysectomized eels. This suggests that extra-pituitary mechanisms mediate, at least partly, the effects of transfer to SW on aromatase activity.
J. Endocr. (1987) 114, 289–294
Journal of Endocrinology is committed to supporting researchers in demonstrating the impact of their articles published in the journal.
The two types of article metrics we measure are (i) more traditional full-text views and pdf downloads, and (ii) Altmetric data, which shows the wider impact of articles in a range of non-traditional sources, such as social media.
More information is on the Reasons to publish page.
| Sept 2018 onwards | Past Year | Past 30 Days | |
|---|---|---|---|
| Full Text Views | 1 | 0 | 0 |
| PDF Downloads | 1 | 0 | 0 |
Online ISSN: 1479-6805
Print ISSN: 0022-0795
Strengthening biomedical communities
to advance science and health
CONTACT US
Bioscientifica Ltd | Starling House | 1600 Bristol Parkway North | Bristol BS34 8YU | UK
Bioscientifica Ltd | Registered in England no 3190519
